Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Head of Cell Line Development CMB at Boehringer Ingelheim Pharma GmbH & Co.KG
Dr. Fischer received his PhD in Pharmaceutical Biotechnology from Ulm University for investigating the role of microRNAs in CHO production cells. Before, he studied Pharmaceutical Biotechnology and Biomedical Engineering at the Universities of Biberach and Albstadt-Sigmaringen, respectively. Dr. Fischer previously worked with Boehringer Ingelheim (BI) Pharma in the Department of CNS Research and Novartis Pharma within the Novartis Biologics Center. After his PhD, Dr. Fischer joined BI again, first as a Post doc and later as Scientist in Cell Culture Development. Since 2017, Dr. Fischer is heading the global Cell Line Development CMB group at BI responsible for customer projects.